Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 3Terminated 2Unknown 1

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 3Lymphoid 2Head & Neck 2Other hematologic neoplasm 1Other 1Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Lymphoma, Follicular 1Anxiety Disorders 1Acute Pain 1

Interventions

Rituximab 227Cyclophosphamide 142fludarabine 69Vincristine 66Methotrexate 62Doxorubicin 54fludarabine phosphate 53Lenalidomide 49Etoposide 49Cytarabine 48Prednisone 47Dexamethasone 44Filgrastim 43Bortezomib 38Whole-Body Irradiation 34Gemcitabine 34Melphalan 32Radiotherapy 30ibrutinib 29Granulocyte Colony-Stimulating Factor 29Alemtuzumab 29obinutuzumab 28Tacrolimus 28Mycophenolic Acid 28Antilymphocyte Serum 28venetoclax 27Calcium Dobesilate 27Busulfan 27Bendamustine Hydrochloride 27idelalisib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Ketamine × Lymphoid × Clear all
NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated
10 enrolled
LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03959852 2020-09-11

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

Mercy Health Ohio

Phase 4 Terminated
6 enrolled
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡